TrialLeukemia2012

Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results.

P D le Coutre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.